Contribution of genetic variants to pain susceptibility in Parkinson disease

European Journal of Pain (United Kingdom)

Volumn 16, Issue 9, 2012, Pages 1243-1250

  Greenbaum, L ^a   Tegeder, I ^b   Barhum, Y ^c   Melamed, E ^c   Roditi, Y ^c   Djaldetti, R ^c,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b GOETHE UNIVERSITY   (Germany)

^c TEL AVIV UNIVERSITY   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FATTY ACID AMIDASE; LEVODOPA; SODIUM CHANNEL NAV1.7; TRYPTOPHAN; AMIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CACNG2 PROTEIN, HUMAN; CALCIUM CHANNEL; CATECHOL METHYLTRANSFERASE; DELTA OPIATE RECEPTOR; FATTY-ACID AMIDE HYDROLASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MELANOCORTIN 1 RECEPTOR; MU OPIATE RECEPTOR; OPRD1 PROTEIN, HUMAN; OPRM1 PROTEIN, HUMAN; SCN9A PROTEIN, HUMAN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DNA EXTRACTION; DYSTONIA; ETHNICITY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RADICULAR PAIN; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; JEW; MIDDLE AGED; PAIN;

AGED; AMIDOHYDROLASES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNELS; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; JEWS; MALE; MIDDLE AGED; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; PAIN; PARKINSON DISEASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRPV CATION CHANNELS;

EID: 84872812654     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2012.00134.x     Document Type: Article

References (44)

1. Aoki, J., Ikeda, K., Murayama, O., Yoshihara, E., Ogai, Y., Iwahashi, K. (2010). The association between personality, pain threshold and a single nucleotide polymorphism (rs3813034) in the 3″-untranslated region of the serotonin transporter gene (SLC6A4). J Clin Neurosci 7, 574-578.
2. Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T.P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., Cicarelli, G., Gaglio, R.M., Giglia, R.M., Iemolo, F., Manfredi, M., Meco, G., Nicoletti, A., Pederzoli, M., Petrone, A., Pisani, A., Pontieri, F.E., Quatrale, R., Ramat, S., Scala, R., Volpe, G., Zappulla, S., Bentivoglio, A.R., Stocchi, F., Trianni, G., Dotto, P.D., PRIAMO Study Group. (2009). The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 24, 1641-1649.
3. Beiske, A.G., Loge, J.H., Rønningen, A., Svensson, E. (2009). Pain in Parkinson's disease: Prevalence and characteristics. Pain 141, 173-177.
4. Chaudhuri, K.R., Schapira, A.H. (2009). Non-motor symptoms of Parkinson's disease: Dopaminergic pathophysiology and treatment. Lancet Neurol 8, 464-474.
5. Chou, W.Y., Yang, L.C., Lu, H.F., Ko, J.Y., Wang, C.H., Lin, S.H., Lee, T.H., Concejero, A., Hsu, C.J. (2006). Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 50, 787-792.
6. Chudler, E.H., Dong, W.K. (1995). The role of the basal ganglia in nociception and pain. Pain 60, 3-38.
7. Di Lorenzo, C., Di Lorenzo, G., Sances, G., Ghiotto, N., Guaschino, E., Grieco, G.S., Santorelli, F.M., Casali, C., Troisi, A., Siracusano, A., Pierelli, F. (2009). Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 10, 349-355.
8. Diatchenko, L., Slade, G.D., Nackley, A.G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S.A., Shagin, D., Max, M.B., Makarov, S.S., Maixner, W. (2005). Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14, 135-143.
9. Djaldetti, R., Shifrin, A., Rogowski, Z., Sprecher, E., Melamed, E., Yarnitsky, D. (2004). Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62, 2171-2175.
10. Doehring, A., Küsener, N., Flühr, K., Neddermeyer, T.J., Schneider, G., Lötsch, J. (2011). Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures. PLoS ONE 6, e17724.
11. Estacion, M., Harty, T.P., Choi, J.S., Tyrrell, L., Dib-Hajj, S.D., Waxman, S.G. (2009). A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol 66, 862-866.
12. Fillingim, R.B., Kaplan, L., Staud, R., Ness, T.J., Glover, T.L., Campbell, C.M., Mogil, J.S., Wallace, M.R. (2005). The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6, 159-167.
13. Ford, B. (2010). Pain in Parkinson's disease. Mov Disord 25 (Suppl 1), S98-S103.
14. Foulkes, T., Wood, J.N. (2008). Pain genes. PLoS Genet 4, e1000086.
15. Gallagher, D.A., Lees, A.J., Schrag, A. (2010). What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25, 2493-2500.
16. Gerdelat-Mas, A., Simonetta-Moreau, M., Thalamas, C., Ory-Magne, F., Slaoui, T., Rascol, O., Brefel-Courbon, C. (2007). Levodopa raises objective pain threshold in Parkinson's disease: A RIII reflex study. J Neurol Neurosurg Psychiatry 78, 1140-1142.
17. Goetz, C.G., Tanner, C.M., Levy, M., Wilson, R.S., Garron, D.C. (1986). Pain in Parkinson's disease. Mov Disord 1, 45-49.
18. Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55, 181-184.
19. Kim, H., Mittal, D.P., Iadarola, M.J., Dionne, R.A. (2006). Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet 43, e40.
20. Kim, H., Neubert, J.K., San Miguel, A., Xu, K., Krishnaraju, R.K., Iadarola, M.J., Goldman, D., Dionne, R.A. (2004). Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain 109, 488-496.
21. Klepstad, P., Rakvåg, T.T., Kaasa, S., Holthe, M., Dale, O., Borchgrevink, P.C., Baar, C., Vikan, T., Krokan, H.E., Skorpen, F. (2004). The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 48, 1232-1239.
22. Lichtman, A.H., Shelton, C.C., Advani, T., Cravatt, B.F. (2004). Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109, 319-327.
23. Lötsch, J., Stuck, B., Hummel, T. (2006). The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci 120, 1218-1224.
24. Mogil, J.S., Wilson, S.G., Chesler, E.J., Rankin, A.L., Nemmani, K.V., Lariviere, W.R., Groce, M.K., Wallace, M.R., Kaplan, L., Staud, R., Ness, T.J., Glover, T.L., Stankova, M., Mayorov, A., Hruby, V.J., Grisel, J.E., Fillingim, R.B. (2003). The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A 100, 4867-4872.
25. Nielsen, C.S., Stubhaug, A., Price, D.D., Vassend, O., Czajkowski, N., Harris, J.R. (2008). Individual differences in pain sensitivity: Genetic and environmental contributions. Pain 136, 21-29.
26. Nissenbaum, J., Devor, M., Seltzer, Z., Gebauer, M., Michaelis, M., Tal, M., Dorfman, R., Abitbul-Yarkoni, M., Lu, Y., Elahipanah, T., Delcanho, S., Minert, A., Fried, K., Persson, A.K., Shpigler, H., Shabo, E., Yakir, B., Pisanté, A., Darvasi, A. (2010). Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res 20, 1180-1190.
27. O'Sullivan, S.S., Williams, D.R., Gallagher, D.A., Massey, L.A., Silveira-Moriyama, L., Lees, A.J. (2008). Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study. Mov Disord 23, 101-106.
28. Potvin, S., Larouche, A., Normand, E., de Souza, J.B., Gaumond, I., Grignon, S., Marchand, S. (2009). DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 10, 969-975.
29. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J., Sham, P.C. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
30. Raymond, C.K., Castle, J., Garrett-Engele, P., Armour, C.D., Kan, Z., Tsinoremas, N., Johnson, J.M. (2004). Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem 279, 46234-46241.
31. Reimann, F., Cox, J.J., Belfer, I., Diatchenko, L., Zaykin, D.V., McHale, D.P., Drenth, J.P., Dai, F., Wheeler, J., Sanders, F., Wood, L., Wu, T.X., Karppinen, J., Nikolajsen, L., Männikkö, M., Max, M.B., Kiselycznyk, C., Poddar, M., Te Morsche, R.H., Smith, S., Gibson, D., Kelempisioti, A., Maixner, W., Gribble, F.M., Woods, C.G. (2010). Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A 107, 5148-5153.
32. Rush, A.M., Dib-Hajj, S.D., Liu, S., Cummins, T.R., Black, J.A., Waxman, S.G. (2006). A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A 103, 8245-8250.
33. Scotter, E.L., Abood, M.E., Glass, M. (2010). The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol 160, 480-498.
34. Solovieva, S., Leino-Arjas, P., Saarela, J., Luoma, K., Raininko, R., Riihimäki, H. (2004). Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain 109, 8-19.
35. Sullivan, P.F. (2007). Spurious genetic associations. Biol Psychiatry 61, 1121-1126.
36. Tegeder, I., Adolph, J., Schmidt, H., Woolf, C.J., Geisslinger, G., Lötsch, J. (2008). Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 12, 1069-1077.
37. Tegeder, I., Costigan, M., Griffin, R.S., Abele, A., Belfer, I., Schmidt, H., Ehnert, C., Nejim, J., Marian, C., Scholz, J., Wu, T., Allchorne, A., Diatchenko, L., Binshtok, A.M., Goldman, D., Adolph, J., Sama, S., Atlas, S.J., Carlezon, W.A., Parsegian, A., Lötsch, J., Fillingim, R.B., Maixner, W., Geisslinger, G., Max, M.B., Woolf, C.J. (2006). GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12, 1269-1277.
38. Urakami, K., Takahashi, K., Matsushima, E., Sano, K., Nishikawa, S., Takao, T. (1990). The threshold of pain and neurotransmitter's change on pain in Parkinson's disease. Jpn J Psychiatry Neurol 44, 589-593.
39. Valdes, A.M., Arden, N.K., Vaughn, F.L., Doherty, S.A., Leaverton, P.E., Zhang, W., Muir, K.R., Rampersaud, E., Dennison, E.M., Edwards, M.H., Jameson, K.A., Javaid, M.K., Spector, T.D., Cooper, C., Maciewicz, R.A., Doherty, M. (2011). Role of the Na(V)1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain. Arthritis Care Res 63, 440-444.
40. van den Oord, E.J., Kuo, P.H., Hartmann, A.M., Webb, B.T., Möller, H.J., Hettema, J.M., Giegling, I., Bukszár, J., Rujescu, D. (2008). Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry 65, 1062-1071.
41. Vossen, H., Kenis, G., Rutten, B., van Os, J., Hermens, H., Lousberg, R. (2010). The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS ONE 5, e13641.
42. Wood, P.B. (2008). Role of central dopamine in pain and analgesia. Expert Rev Neurother 8, 781-797.
43. Yang, Y., Wang, Y., Li, S., Xu, Z., Li, H., Ma, L., Fan, J., Bu, D., Liu, B., Fan, Z., Wu, G., Jin, J., Ding, B., Zhu, X., Shen, Y. (2004). Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 41, 171-174.
44. Zubieta, J.K., Heitzeg, M.M., Smith, Y.R., Bueller, J.A., Xu, K., Xu, Y., Koeppe, R.A., Stohler, C.S., Goldman, D. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299, 1240-1243.